Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

69 results about "Gluconacetobacter xylinum" patented technology

One continuing mystery surrounding microbial cellulose is its exact biological function. A. xylinus, since been renamed as Gluconacetobacter xylinus and more recently as Komagataeibacter xylinus, is a successful and prevalent bacterium in nature, frequently finding a home in rotting fruits and sweetened liquids.

Method for preparing Fe3O4 magnetotactic bacterial cellulose spheres

The invention relates to a method for preparing Fe3O4 magnetotactic bacterial cellulose spheres. The method comprises the following steps of: preparing nanoscale Fe3O4 (with superparamagnetism) by a coprecipitation method; sterilizing the nanoscale Fe3O4 and a fermentation culture medium respectively and mixing; inoculating gluconacetobacter xylinum (CGMCC No. 2955); controlling the rotate speed of a shaker and culture time to obtain magnetotactic cellulose spheres with different diameters; immersing and washing the magnetotactic cellulose spheres in flowing water for one hour to remove the residual thalli and the culture medium; and washing by using deionized water for five times (the using amount of deionized water every time is 500 milliliters). Due to inconsistent diameters of the magnetotactic bacterial cellulose spheres formed by fermentation, the magnetotactic bacterial cellulose spheres with required diameters can be screened out by using a screen plate with a certain bore diameter, and Fe3O4 particles are distributed uniformly and wrapped in the bacterial cellulose spheres layer by layer along with the biosynthesis and secretion of bacterial cellulose (BC). The magnetotactic bacterial cellulose spheres can be used as a vector of immobilized enzyme or cells, and have the advantage that: after a reaction is finished, the magnetotactic bacterial cellulose spheres are separated by a magnetic field, and can be used repeatedly after the magnetic field is removed.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Method for improving plasticity and flexibility of bacterial cellulose membrane

The invention relates to a method for improving the plasticity and flexibility of a bacterial cellulose membrane. Microbial Gluconacetobacter xylinum is cultured by static culture so as to obtain an initial bacterial cellulose wet membrane sample, and after the sample is soaked in alkaline liquor and then soaked and purified in deionized water, the purified bacterial cellulose membrane is soaked into polyether amine salt solutions with different concentrations (1-5.2wt%) firstly, the obtained object is put into an oscillator to oscillate and compound for 24h at room temperature, and then the compounded bacterial cellulose membrane/polyether amide membrane, after being washed by using deionized water, is dried at certain temperature, the plasticity of the obtained final bacterial cellulose/polyether amine compounded membrane is 45.8%, compared with the plasticity 4% of a bacterial cellulose membrane before compounding, the plasticity of the compounded cellulose membrane is increased by 11.45 times, so that the bacterial cellulose is applied more widely to the fields of chemical engineering, paper making and biomedicine; and in addition, the method is low in production and operation costs, less in equipment investment, and high in feasibility.
Owner:TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY

Completely degradable tissue engineering skin scaffold material and preparation method thereof

The invention discloses a completely degradable tissue engineering skin scaffold material which comprises two parts, namely, a bacterial cellulose/chitosan nanofiber layer and a large-aperture array micron fiber scaffold. The bacterial cellulose/chitosan nanofiber layer is an upper layer, the upper part of the large-aperture array micron fiber scaffold is a lower layer, and the layers are crosslinked and combined through glutaraldehyde. The bacterial cellulose/chitosan nanofiber layer is formed by in-situ synthesis of gluconacetobacter xylinum, and cellulase is fixed on the surface of the bacterial cellulose/chitosan nanofiber layer. The large-aperture array micron fiber scaffold is a scaffold formed by arranging electrostatic spinning lactic acid/hyaluronic acid/fibroin micro-nano fibersin an orderly manner, and the surface of the large-aperture array micron fiber scaffold is modified with polylactic acid-glycolic acid growth factor sustained-release microspheres. The used raw materials are non-toxic and harmless, the fiber property is stable, and good biocompatibility is achieved. The scaffold material can be completely degraded in vivo. The pore diameter of the lower-layer scaffold is close to the cell size, and cells can enter the scaffold. Growth factors can be stably released, and skin tissue regeneration is facilitated.
Owner:广州市拜沃思生物科技有限公司

Method and device for producing shaped microbial cellulose for use as biomaterial especially for microsurgery

The use of exogenic materials for replacing blood vessels carries the risk of thrombosis and is therefore particularly unsuitable for microsurgical applications (inner vessel diameters of 1-3 mm and less), or only suitable under certain conditions. Replacements of blood vessels with a very small lumen in particular require biomaterials which guarantee that the surfaces of the prosthesis that come into contact with the blood are of a very high quality, and which reliably avoid this kind of thrombosis adhesion. The biomaterial is produced by immersing shaped body walls, especially of a glass matrix consisting of a glass tube and glass body, in a container of an inoculated nutrient solution so that the inoculated nutrient solution is drawn into the area between the walls of the shaped body and cultivation takes place in a moist, aerobic environment. In each subsequent cultivation process, an unused shaped body (glass body) is used as the shaped body wall for shaping the surface of the prosthesis material that is to come into contact with the blood when the biomaterial is used. This is the only sure way of reproducing the high surface quality of the vessel prosthesis and hereby reliably preventing thrombosis adhesion on the biomaterial used. The inventive method is particularly suitable for microsurgical applications, especially for replacing blood vessels and other internal hollow organs or as a cuff for covering nerve fibres, etc.
Owner:SURA CHEM GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products